Tafazzin Antibody

• Catalog Number: orb19073
• Category: Antibodies
• Description: Goat polyclonal antibody to TAZ
• Target: Tafazzin
• Clonality: Polyclonal
• Species/Host: Goat
• Conjugation: Unconjugated
• Reactivity: Human
• Predicted Reactivity: Canine, Mouse, Rat
• Buffer/Preservatives: Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH 7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.
• Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
• Protein Sequence: HLKTQAEQLHNH
• RRID: AB_10755755
• MW: 33.5; 30.2; 31.7; 28.5
• Tested applications: ELISA, WB
• Dilution range: ELISA: 1:32000, WB: 0.3-1.0 μg/ml
• Application notes: ELISA: Peptide ELISA: antibody detection limit dilution 1:32000.WB: Approx 28kDa band observed in Human Heart lysates (calculated MW of 33.5kDa according to NP_000107.1, 30.2kDa according to NP_851828.1, 31.7kDa according to NP_851829.1 and 28.5 according to NP_851830.1). Recommended concentration: 0.3-1.0 μg/ml.
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Alternative names: anti TAZ antibody, anti tafazzin (cardiomyopathy,
• Note: For research use only
• Entrez: 6901

orb19073 (0.3ug/ml) staining of Human Heart lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.

1 µg/mL staining of Human Testes lysate (35 µg protein in RIPA buffer). Detected by chemiluminescence.